Barclays PLC (BCS) Stock Price & How to Invest

Barclays PLC (NYSE: BCS) is one of the largest banks headquartered in the United Kingdom, operating a universal-banking model across five divisions: Barclays UK (personal banking, UK business banking, and Barclaycard consumer cards inside the ring-fenced bank), the UK Corporate Bank (lending, trade, payments, and FX for corporate clients), Private Bank and Wealth Management, the Investment Bank (Global Markets trading, investment banking advisory and underwriting, and international corporate banking), and the US Consumer Bank (a partnership-focused credit-card business plus an online deposit franchise). The US-listed security is an American Depositary Receipt, with each ADR representing four Barclays ordinary shares. The bank earns money from net interest income (the spread between what it charges on loans and cards and what it pays on deposits) and from fee and trading income across markets, banking, cards, and wealth.

The investment picture centers on management's plan, laid out in 2024, to raise group return on tangible equity while shrinking the relative size of the more capital-hungry investment bank and growing higher-returning UK and consumer businesses. In full-year 2025 Barclays reported group income of about 29.1 billion pounds (up ~9%), profit before tax of about 9.1 billion pounds (up ~13%), earnings per share up ~22% to 43.8 pence, and a return on tangible equity of ~11.3%, with all divisions delivering double-digit returns and a strong CET1 capital ratio of ~14.3%. It set new medium-term targets of group RoTE above 12% in 2026 and above 14% in 2028. In the first quarter of 2026 it posted RoTE of ~13.5%, its investment bank crossed 4 billion pounds of quarterly income for the first time, and it announced a 500 million pound share buyback as part of a commitment to return more than 10 billion pounds to shareholders across 2024-2026 and more than 15 billion pounds across 2026-2028. Like all banks, Barclays remains sensitive to interest rates, the credit cycle, and market volatility.

The second quarter of 2026 kept that momentum going. Barclays reported revenue of about 8.3 billion pounds, up roughly 16% on a year earlier, and quarterly earnings of about 2.3 billion pounds, the highest in the last four quarters, with earnings per ADR slightly ahead of the analyst consensus (0.89 vs 0.87 on Yahoo Finance's figures), its fourth consecutive small beat. Trailing twelve-month revenue is now about 28.1 billion pounds and net income about 6.8 billion pounds. The share price has not followed: as of October 16, 2026 the ADR was about 11% lower year to date and about 17% lower over three months, though still about 16% above its level of a year earlier, inside a 52-week range of roughly $19.29-28.69. Third-quarter results are scheduled for October 22, 2026, with consensus looking for revenue of about 7.6 billion pounds. Recent headlines also point to Barclays planning to re-enter India's equity capital markets business.

Barclays is highly sensitive to interest rates, since net interest income is a major revenue line and falling rates or deposit repricing can compress margins. As an economically cyclical bank it is exposed to the credit cycle, and rising impairment charges, which weighed on first-quarter 2026 earnings, can eat into profit when unemployment or defaults rise, particularly in its US and UK card books. The investment bank adds earnings volatility because trading and deal revenue swing with market conditions, and it is capital-intensive and competes with far larger Wall Street firms. As a UK-domiciled bank, results also reflect the British and European macro backdrop, regulatory and ring-fencing rules, and periodic conduct or litigation costs. Finally, for US investors the ADR carries currency risk, since earnings and dividends are generated in pounds and translated into dollars. The share price itself has been volatile in 2026, falling about 17% in the three months to mid-October even as reported earnings rose, which shows how quickly sentiment toward European banks can move independently of results.

4 analysts publish price targets on BCS, averaging $29.92 against a $22.79 price as of October 2026, or +31.3%. The published targets run from $27.10 to $33.50, a narrow spread, and the ratings split 1 buy, 3 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BCS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Barclays PLC. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Returns-improvement plan and 2026-2028 targets. Barclays is executing a multi-year plan to lift group return on tangible equity, reporting ~11.3% for full-year 2025 and setting targets of above 12% in 2026 and above 14% in 2028. The most optimistic published target, $33.50, assumes this works close to its best case.

The case against. Barclays is highly sensitive to interest rates, since net interest income is a major revenue line and falling rates or deposit repricing can compress margins. The most pessimistic target, $27.10, is roughly what BCS is worth if this bites instead.

Read the full bull and bear case on BCS, including what would have to change to break either one. Walnut is not an investment adviser.

No. Barclays PLC (BCS) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Barclays PLC's investor relations page or your broker.

• Revenue (TTM): ~£28.1 billion
• Revenue Growth (Q2 2026, YoY): ~16%
• Net Income (TTM): ~£6.8 billion (profit margin ~28%)
• Return on Tangible Equity (FY2025): ~11.3% (target >12% in 2026, >14% in 2028)
• Price-to-Earnings (trailing / forward): ~8.9x / ~7.1x
• Price-to-Book: ~0.9x
• Dividend Yield (ADR): ~2.7%
• Market Capitalization (ADR): ~$77 billion

After a roughly 17% three-month decline, Barclays trades at about 9x trailing and 7x forward earnings and about 0.9x book as of October 16, 2026, cheaper than earlier in the year even though first-half 2026 profit grew strongly. Each NYSE ADR represents four UK-listed ordinary shares, so the ADR price reflects four underlying shares translated from pounds into dollars. Capital returns run through a progressive dividend (about a 2.7% yield) and recurring buybacks, and third-quarter results arrive on October 22, 2026.

Other names that sit close to BCS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BCS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BCS sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BCS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Barclays is a large-cap, economically cyclical global bank in the middle of a returns-improvement plan, returning capital through a rising dividend and buybacks, with its investment bank adding both diversification and volatility. Earnings have grown quickly in 2026 (first-half revenue and profit both up sharply on 2025), yet the ADR has fallen about 17% over the past three months to roughly 9x trailing and 7x forward earnings and about 0.9x book, so the October 22 third-quarter report is the next test of whether the returns plan is on track.

Whether BCS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BCS a buy or a sell?, and where the stock could go from here in the BCS stock forecast.

For income investors, whether BCS pays a dividend and how the payout looks is covered in does BCS pay a dividend? And to weigh BCS against a peer, read the full side-by-side comparisons: BCS vs LYG and BCS vs NWG.